NEO

NeoGenomics Inc

NEO, USA

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

https://www.neogenomics.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NEO
stock
NEO

NeoGenomics, Inc. $NEO Shares Acquired by Squarepoint Ops LLC MarketBeat

Read more →
NEO
stock
NEO

NeoGenomics (NASDAQ: NEO) retains RaDaR patent ruling as Natera withdraws appeal Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$13.1667

Analyst Picks

Strong Buy

6

Buy

2

Hold

6

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.36

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-3.24 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-1.97 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.30 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Medium

0.64

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 106.83% of the total shares of NeoGenomics Inc

1.

BlackRock Inc

(15.037%)

since

2025/06/30

2.

Vanguard Group Inc

(10.9389%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(5.9269%)

since

2025/08/31

4.

Greenhouse Funds LLLP

(5.7526%)

since

2025/06/30

5.

First Light Asset Management, LLC

(5.3%)

since

2025/06/30

6.

State Street Corp

(3.9566%)

since

2025/06/30

7.

Macquarie Group Ltd

(3.7215%)

since

2025/06/30

8.

Dimensional Fund Advisors, Inc.

(3.3238%)

since

2025/06/30

9.

Vanguard Total Stock Mkt Idx Inv

(3.1234%)

since

2025/07/31

10.

Schroder Investment Management Group

(2.882%)

since

2025/06/30

11.

Macquarie Small Cap Core I

(2.7946%)

since

2025/07/31

12.

American Century Companies Inc

(2.723%)

since

2025/06/30

13.

Millennium Management LLC

(2.5676%)

since

2025/06/30

14.

T. Rowe Price Investment Management,Inc.

(2.5246%)

since

2025/06/30

15.

Geode Capital Management, LLC

(2.4436%)

since

2025/06/30

16.

Vanguard Small Cap Index

(2.4154%)

since

2025/07/31

17.

iShares Russell 2000 ETF

(2.3938%)

since

2025/08/31

18.

American Century U.S. Small Cap Growth

(2.1301%)

since

2025/06/30

19.

American Century Small Cap Growth Inv

(2.1301%)

since

2025/06/30

20.

Morgan Stanley - Brokerage Accounts

(1.9264%)

since

2025/06/30

21.

GW&K Investment Management, LLC

(1.9159%)

since

2025/06/30

22.

Segall Bryant & Hamill

(1.8285%)

since

2025/06/30

23.

Deerfield Management Co

(1.6628%)

since

2025/06/30

24.

HHG PLC

(1.5487%)

since

2025/06/30

25.

Vanguard Small Cap Growth Index Inv

(1.3545%)

since

2025/07/31

26.

Jennison Associates LLC

(1.2881%)

since

2025/06/30

27.

Bank of America Corp

(1.1604%)

since

2025/06/30

28.

Goldman Sachs Group Inc

(1.149%)

since

2025/06/30

29.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0675%)

since

2025/07/31

30.

Franklin US Small Cap Growth Equity

(1.05%)

since

2025/06/30

31.

Janus Henderson US Small Cap Growth

(1.0133%)

since

2025/06/30

32.

Janus Henderson Venture D

(1.0133%)

since

2025/06/30

33.

Fidelity Small Cap Index

(1.0035%)

since

2025/06/30

34.

Franklin Small Cap Growth Adv

(0.9654%)

since

2025/07/31

35.

T. Rowe Price US Small-Cap Core Equity

(0.9159%)

since

2025/06/30

37.

iShares Russell 2000 Value ETF

(0.8002%)

since

2025/08/31

38.

Glenmede Small Cap Equity Adv

(0.7575%)

since

2025/06/30

39.

Glenmede Small Cap Equity

(0.7575%)

since

2025/06/30

40.

Schroder US Smaller Companies Acc

(0.6897%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.03

EPS Estimate

0.0208

EPS Difference

0.0092

Surprise Percent

44.2308%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(4)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.